Simplifying Global Compliance
SEC Probes Teva Over Possible FCPA Violations in Latin America
Washington Drug Letter
Teva Pharmaceuticals is the target of an SEC bribery investigation and has been handed a subpoena for documents related to its compliance with the Foreign Corrupt Practice Act (FCPA) in Latin America.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing